Sid Paquette will now head RBC Ventures and RBCx
Posted in General

RBCx hires former SVB Canada employees to bolster support for seed-stage and life sciences startups

RBC joins growing list of Canadian banks to add talent from now-defunct SVB Canada. The Royal Bank of Canada’s technology and innovation arm, RBCx,…

Continue Reading RBCx hires former SVB Canada employees to bolster support for seed-stage and life sciences startups
Deep Genomics adds life sciences veteran as CEO to support its evolution into biopharma firm
Posted in General

H|T: The Healthtech Times – Deep Genomics adds life sciences veteran, Papa loses major contracts

Plus: Digital health, health IT funding slumped in Q2, but some bright spots remain. The Healthtech Times is a weekly newsletter covering healthtech news…

Continue Reading H|T: The Healthtech Times – Deep Genomics adds life sciences veteran, Papa loses major contracts
Deep Genomics adds life sciences veteran as CEO to support its evolution into biopharma firm
Posted in General

Deep Genomics adds life sciences veteran as CEO to support its evolution into biopharma firm

Brian O’Callaghan to lead Toronto firm as founder transitions to chief innovation officer. Toronto-based artificial intelligence (AI) drug development startup Deep Genomics has hired…

Continue Reading Deep Genomics adds life sciences veteran as CEO to support its evolution into biopharma firm
USD and CAD cash
Posted in General

Over $1 million in cash available for Canadian startups in FinTech, sciences, and more

Startups can now apply for a chance to get funding from Momentum, Innovate BC, and Platform Calgary. There is $1.6 million up for grabs…

Continue Reading Over $1 million in cash available for Canadian startups in FinTech, sciences, and more
The many hurdles life sciences startups must overcome to commercialize
Posted in General

The many hurdles life sciences startups must overcome to commercialize

Startups need cash, time, and connections. Alex Muggah has seen hundreds of life sciences and healthtech companies work to commercialize their innovations. If new…

Continue Reading The many hurdles life sciences startups must overcome to commercialize
ACTO secures $23.5 million CAD as pandemic tailwinds increase demand for life sciences education
Posted in General

ACTO secures $23.5 million CAD as pandemic tailwinds increase demand for life sciences education

AstraZeneca is one of ACTO’s biggest customers. With a focus on training and data tracking for life sciences salespeople, ACTO has secured $23.5 million…

Continue Reading ACTO secures $23.5 million CAD as pandemic tailwinds increase demand for life sciences education